Despite technological advances, most of medicine is still stubbornly one-size-fits-all. But last month, we got one step closer to personalized treatments.
The Big Decline In This Stock Is A Gift To Investors
Despite technological advances, most of medicine is still stubbornly one-size-fits-all. But last month, we got one step closer to personalized treatments.